Showing 1261-1270 of 1457 results for "".
Case Report, Plus Top Resident Presentations from CSF 2014, and Ask an Expert
https://practicaldermatology.com/youngmd-connect/resident-resource-center/case-report-plus-top-resident-presentations-from-csf-2014-and-ask-an-expert/21226/From Clinic to Capitol: Tips for Building Grassroots and Legislative Support For Anti-Tanning Policies in Your State
https://practicaldermatology.com/topics/skin-cancer-photoprotection/from-clinic-to-capitol-tips-for-building-grassroots-and-legislative-support-for-anti-tanning-policies-in-your-state/22943/It's no easy task to shepherd legislation through state assemblies, but dermatologists' clinical standing can have some influence.Developing Core Outcome Sets: The Importance of Common Standards for Clinical Studies of Specific Diseases and Conditions
https://practicaldermatology.com/topics/feature/developing-core-outcome-sets-importance-common-standards-clinical-studies-specific-diseases-and-conditions/26654/Developing Core Outcome Sets: The Importance of Common Standards for Clinical Studies of Specific Diseases and ConditionsTherapeutics Focus: Corticosteroids
https://practicaldermatology.com/topics/psoriasis/therapeutics-focus-corticosteroids/21432/New products and pharmacologic developmentsFringe Benefit Plans: Valuable Planning Tools You Haven't Heard Of
https://practicaldermatology.com/topics/practice-management/fringe-benefit-plans-valuable-planning-tools-you-havent-heard-of/21488/Fringe benefit plans lack many of the restrictions of qualified plans and, therefore, are relatively inexpensive to implement.Robotic Technology Brings New Benefits to Patients and Practices
https://practicaldermatology.com/topics/general-topics/robotic-technology-brings-new-benefits-to-patients-and-practices/21501/Can the new trend in robotic surgery benefit cosmetic dermatology practices?Bimekizumab-bkzx Journal Scan: 4 Clinical Trials
https://practicaldermatology.com/topics/digital-supplement/bimekizumab-bkzx-journal-scan-4-clinical-trials/24128/Speed, depth, and durability from the first dual IL-17A/F inhibitor for the treatment of moderate to severe plaque psoriasis.Recent Developments
https://practicaldermatology.com/columns/recent-developments/news/20326/Recent Developments
https://practicaldermatology.com/columns/recent-developments/recent-developments-5/23092/Cosmetics Challenge
https://practicaldermatology.com/topics/general-topics/cosmetics-challenge/21793/